#USA #FDA Clearance #San Carlos #Earflo #pediatric ear care

Earflo Launches Revolutionary Device for Ear Treatment

Earflo, a groundbreaking medical technology company, is excited to announce the U.S. market availability of its FDA-cleared device designed specifically for addressing negative middle ear pressure in children as young as two. This innovative solution offers families a non-surgical option during the critical 'watchful waiting' period that precedes surgical intervention.

The newly launched device is not just an ordinary medical tool; it has been recognized by prestigious platforms such as TIME and CES for its breakthrough design and functionality. Millions of children experience issues related to negative middle ear pressure, often resulting in fluid buildup that necessitates ear tube surgery—the most prevalent pediatric surgery in the United States. With the Earflo device, families can now tackle these concerns at home effectively and safely.

How Earflo Works

The Earflo device functions by delivering a precisely-controlled puff of air through the nose into the eustachian tube while the child swallows, thereby helping to equalize middle ear pressure and minimize fluid accumulation associated with conditions like otitis media with effusion (OME). This non-invasive procedure is designed as a child-friendly cup and comes with a companion mobile app that not only guides therapy sessions but also incorporates fun, child-friendly games to resonate with the young users. The app enables parents and clinicians to monitor therapy progress efficiently.

Dr. Intan Oldakowska, Earflo’s CEO and co-founder, emphasized the emotional burden parents face while watching their children endure ear pain and hearing difficulties. She stated, “Our mission is to provide a straightforward, science-backed solution families can utilize at home to prevent these conditions from escalating to surgical procedures.”

Addressing Childhood Ear Conditions

Otitis media with effusion is a condition that impacts approximately 90% of children by age five. If left untreated, persistent cases can lead to critical challenges in hearing and speech development. Traditional methods often require a lengthy three-month observation period, leading to concerns about how this could hinder children’s learning opportunities and daily activities. In cases where symptoms do not abate, physicians frequently recommend ear tube surgery, which affects nearly one million children annually in the U.S.

Reflecting on these challenges, Dr. Peter Santa Maria, Earflo's Chief Medical Officer, noted how Earflo redefines the approach to pediatric ear care. He remarked, “For the first time, parents are empowered with a proactive solution, and clinical data showcases its effectiveness.” Recent peer-reviewed studies reveal that 86% of children experienced immediate pressure improvement, and four weeks post-treatment, 86% showed significant listening enhancements, allowing 89% to avoid surgery altogether.

Recognition and Future Goals

Earflo’s commitment to advancing pediatric ear care hasn’t gone unnoticed. The company has garnered multiple accolades, including being featured in TIME's Best Inventions of 2025 and winning the CES Innovation Awards® Best of Innovation in Digital Health and a Gold Anthem Award for Health Innovation. These honors underline the sophisticated design and engineering expertise poured into creating an intuitive, child-friendly treatment that doesn’t compromise on medical-grade efficacy.

Additionally, mission-oriented investments from prominent organizations such as the Richard King Mellon Foundation, Eye and Ear Foundation of Pittsburgh, and Australian Medical Angels have bolstered Earflo’s journey toward FDA clearance and mass production.

As Earflo continues to gain FDA clearance and broaden its U.S. distribution through pediatric healthcare providers and consumer channels, it aims to ensure that families have access to effective alternatives for managing children’s ear-related conditions. Dr. Oldakowska reiterated the mission—“We strive to simplify, secure, and enhance access to pediatric ear care solutions.”

About Earflo

Earflo is at the forefront of non-invasive treatment approaches for negative middle ear pressure, aiming to mitigate fluid accumulation and persistent ear infections in young children. The innovative device merges superior pressure therapy technology with a design crafted for kids, fostering ease of use and consistency in treatment. Under the guidance of biomedical engineers and ENT specialists, Earflo stands as a testament to what can be achieved through informed intent and technological innovation in healthcare. For more information, visit earflocare.com.